A Curriculum for Clinical Research Training in Vermont

描述(由申请者提供)：该项目的总体目标是通过提高临床和转化研究的数量和质量来改善所有美国人的健康。在已建立和成功的课程的基础上，我们计划扩大课程和培训机会的提供，扩大我们的学习者受众，将课程更全面地整合到大学的电子学习系统中，并改进计划中对指导的结构化支持。三年来，我们的具体目标是： 为外科医生开设一个新的临床和翻译科学硕士课程，课程内容专门针对年轻外科研究人员的需要而设计 开设两门新的生物信息学课程 开设质量改进的新课程 为临床研究人员开设生物统计学高级专题新课程 与州和社区机构合作，提供二次数据分析实践 通过远程学习技术提供更多核心课程 为每个研究员提供至少两名高质量的导师 我们的第一届研究生毕业于临床和转化学哲学博士学位此外，我们计划继续吸引、教育、评估、支持和毕业临床医生和科学家，以提高高影响临床和转化性研究的质量和数量。 公共卫生相关性(由申请人提供)：该项目旨在通过提高在美国进行的临床和转译研究的质量和数量来改善卫生保健。我们将通过扩大和加强在佛蒙特州培训调查人员的既定课程来实现这一点。

DESCRIPTION (provided by applicant): The overall goal of this project is to improve the health of all Americans by enhancing the quantity and quality of clinical and translational research. Building on an established and successful curriculum, we plan to expand the offerings of courses and training opportunities, widen our audience of learners, integrate the curriculum more fully into the University's electronic learning system, and improve the structured support for mentoring in the program. Over three years, our specific aims are to: Inaugurate a new Master of Science in Clinical and Translational Science program for surgeons with course work designed especially for the needs of young surgical investigators Offer two new courses in Bioinformatics Offer a new course in Quality Improvement Offer a new course in Advanced Topics in Biostatistics for Clinical Investigators Offer a practicum on Secondary Data Analysis in cooperation with state and community agencies Offer more of the core curriculum via distance learning techniques Provide at least two high-quality mentors for every fellow Graduate our first class of graduate students with the Doctor of Philosophy in Clinical and Translational Science degree In addition, we plan to continue to attract, educate, evaluate, support and graduate clinicians and scientists to increase the quality and quantity of high-impact clinical and translational investigation. PUBLIC HEALTH RELEVANCE (provided by the applicant): This project aims to improve health care by increasing the quality and quantity of clinical and translational research done in America. We will accomplish this by expanding and enhancing an established curriculum to train investigators in Vermont.